Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Director/PDMR Shareholding

29 Sep 2017 09:18

RNS Number : 2223S
Mobeus Income & Growth 4 VCT PLC
29 September 2017
 

 

Mobeus Income & Growth 4 VCT plc

 

29 September 2017

 

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility

 

The Company announces that on 28 September 2017, the following Director was allotted and issued the numbers of Ordinary Shares shown below at an average price of 0.895 pence per Ordinary Share. The allotments were made under the Company's Offer for subscription:

 

 Director

Ordinary shares allotted

Percentage of issued share capital acquired

Total notifiable holding following the transaction

Percentage of issued share capital and total voting rights following the transaction

Christopher Moore

11,170

0.002

52,529

0.01

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4(1).

 

 

For further information please contact:

 

Jonathan McGuire at Mobeus Equity Partners LLP, Company Secretary, on 020 7024 7600.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSEMSAUFWSEFU
Date   Source Headline
26th Mar 201912:33 pmRNSAnnual Financial Report
20th Mar 20194:07 pmRNSAnnual Results for the year ended 31 December 2018
20th Dec 201810:13 amRNSTransaction in Own Shares
26th Nov 20189:23 amRNSTransaction in Own Shares
16th Nov 20189:55 amRNSInterim Management Statement - 3rd Quarter Results
27th Sep 201811:11 amRNSTransaction in Own Shares
15th Aug 20185:09 pmRNSSubmission to the NSM
14th Aug 201811:37 amRNSDividend Investment Scheme - Suspension
14th Aug 201811:15 amRNSDividend Investment Scheme - Suspension
14th Aug 201810:39 amRNSHalf-year Report
20th Jun 201810:31 amRNSIssue of Equity
6th Jun 20189:33 amRNSTransaction in Own Shares
11th May 20182:34 pmRNSInterim Management Statement
11th May 20182:30 pmRNSResult of AGM
11th May 20182:26 pmRNSDividend Declaration
26th Mar 20188:50 amRNSTransaction in Own Shares
22nd Mar 20182:37 pmRNSAnnual Financial Report
20th Mar 20185:39 pmRNSAnnual Financial Report
13th Mar 20184:33 pmRNSIssue of Equity
25th Jan 201812:02 pmRNSIssue of Equity
5th Jan 201812:40 pmRNSRealisation of Investment in Gro-Group
5th Jan 201811:23 amRNSTotal Voting Rights
21st Dec 20174:33 pmRNSIssue of Equity
21st Dec 201711:49 amRNSTransaction in Own Shares
20th Dec 20171:57 pmRNSPublication of Suppl.Prospcts
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:30 amRNSIssue of Equity
21st Nov 20175:12 pmRNSDividend Declaration
21st Nov 201710:02 amRNSIssue of Equity
16th Nov 20172:01 pmRNSInterim Management Statement
10th Nov 201710:27 amRNSIssue of Equity
1st Nov 201712:44 pmRNSIncrease in Offer size. Expiry of early incentive.
20th Oct 20172:24 pmRNSDirector/PDMR Shareholding
20th Oct 20172:22 pmRNSIssue of Equity
13th Oct 20172:48 pmRNSDecision to utilise over-allotment facility
29th Sep 201710:24 amRNSDirector/PDMR Shareholding - Replacement
29th Sep 20179:18 amRNSDirector/PDMR Shareholding
29th Sep 20179:17 amRNSIssue of Equity
18th Sep 20179:09 amRNSTransaction in Own Shares
11th Sep 20174:35 pmRNSIssue of Equity
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
8th Aug 20175:34 pmRNSHalf-year Report
8th Aug 20173:53 pmRNSHalf-year Report
4th Aug 20175:10 pmRNSJoint Announcement - Fundraising Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.